Paris-based Sanofi announced plans to increase the company’s vaccines research and production capabilities.

German-based life sciences giant Bayer AG is digging a deep foundation in the booming biotech hub of Boston.

Novo Nordisk – the world’s top maker of diabetes drugs – is investing 115 million pounds ($145 million) in a new research center in Britain, undeterred by Brexit.